Tempest Therapeutics, Inc. ( NASDAQ:TPST – Get Free Report ) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 25,800 shares, a decrease of 39.3% from the June 15th total of 42,500 shares. Based on an average daily trading volume, of 269,500 shares, the short-interest ratio is currently 0.1 days. Currently, 0.5% of the company's stock are short sold. Hedge Funds Weigh In On Tempest Therapeutics A hedge fund recently bought a new stake in Tempest Therapeutics stock.

https://www.dailypolitical.com/2023/07/16/tempest-therapeutics-inc-nasdaqtpst-short-interest-update.html

#dailypolitical